Cascades Capital Asset Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$122K Sell
1,344
-485
-27% -$44.3K 0.05% 147
2026
Q1
$188K Sell
1,829
-37
-2% -$4.18K 0.08% 132
2025
Q4
$234K Sell
1,866
-21
-1% -$2.67K 0.1% 119
2025
Q3
$253K Sell
1,887
-19
-1% -$2.49K 0.11% 112
2025
Q2
$259K Buy
1,906
+226
+13% +$29.8K 0.13% 91
2025
Q1
$223K Buy
+1,680
New +$214K 0.12% 104

Other funds holding ABT

Cascades Capital Asset Management's ABT Position: Q2 2026 in Review

Cascades Capital Asset Management reduced its Abbott (ABT) stake by 27% in Q2 2026, selling an estimated $44.3K and leaving 1,344 shares worth $122K. The position accounts for 0.05% of the portfolio, ranked #147.

Cascades Capital Asset Management first reported a position in ABT in Q1 2025 and has held it in 6 quarters since. The position peaked at $259K in Q2 2025. 2,975 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Cascades Capital Asset Management held 1,344 shares of Abbott worth $122K as of Q2 2026.
  • Cascades Capital Asset Management sold 485 Abbott shares in Q2 2026, an estimated $44.3K.
  • Abbott made up 0.05% of Cascades Capital Asset Management's portfolio in Q2 2026, its #147 holding.
  • Cascades Capital Asset Management first reported a position in Abbott in Q1 2025 and has held it in 6 quarters since.
  • Cascades Capital Asset Management's Abbott position peaked at $259K in Q2 2025.
  • 2,975 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Cascades Capital Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.